Conversation with The Cancer Letter Attorney: Moffitt has made a “very irresponsible decision”—Thomas Sellers “never was a participant” in China’s Thousand Talents Program January 24, 2020Vol.46 No.04By Matthew Bin Han Ong
Moffitt’s internal investigation: Scientists did not disclose funding from state-sponsored programs in China January 24, 2020Vol.46 No.04
Report describes offshore accounts held by Moffitt scientists involved in China’s Thousand Talents programLawyer for former director Thomas Sellers says it's "Nonsense," prepares defamation suit January 24, 2020Vol.46 No.04By Matthew Bin Han Ong
Turman named president of ACT for NIH, group credited with boosting research funding January 17, 2020Vol.46 No.03By Paul Goldberg
NCI increases funding for extramural research by $210M in FY2020; funds more than 125 additional competing awards January 17, 2020Vol.46 No.03By Matthew Bin Han Ong
Conversation with The Cancer LetterFree Robert Winn holds forth on big data, bench-to-community research—and being the only African American director of an NCI-designated cancer center January 17, 2020Vol.46 No.03By Paul Goldberg
Trials & Tribulations Advancing the science of cancer in Latinos January 10, 2020Vol.46 No.02By Amelie G. Ramirez and Ruben A. Mesa
NCI advisors approve seven concepts at joint NCAB/BSA meeting January 10, 2020Vol.46 No.02By Alexandria Carolan
Annals corrects NutriRECS red, processed meat papers to reflect industry-related funding from Texas A&M AgriLife January 10, 2020Vol.46 No.02By Matthew Bin Han Ong
